Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-022928
Filing Date
2022-08-15
Accepted
2022-08-15 16:45:42
Documents
139
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1271158
2 ex10-2.htm EX-10.2 18473
3 ex10-3.htm EX-10.3 25009
4 ex31-1.htm EX-31.1 21130
5 ex31-2.htm EX-31.2 20898
6 ex32-1.htm EX-32.1 6918
7 ex32-2.htm EX-32.2 6995
8 ex10-2_001.jpg GRAPHIC 91532
9 ex10-2_002.jpg GRAPHIC 393337
10 ex10-2_003.jpg GRAPHIC 296395
11 ex10-2_004.jpg GRAPHIC 366551
12 ex10-2_005.jpg GRAPHIC 333186
13 ex10-2_006.jpg GRAPHIC 379910
14 ex10-2_007.jpg GRAPHIC 369521
15 ex10-2_008.jpg GRAPHIC 383931
16 ex10-2_009.jpg GRAPHIC 445822
17 ex10-2_010.jpg GRAPHIC 409140
18 ex10-2_011.jpg GRAPHIC 389783
19 ex10-2_012.jpg GRAPHIC 331296
20 ex10-2_013.jpg GRAPHIC 285847
21 ex10-2_014.jpg GRAPHIC 353442
22 ex10-2_015.jpg GRAPHIC 369122
23 ex10-2_016.jpg GRAPHIC 326322
24 ex10-2_017.jpg GRAPHIC 303958
25 ex10-2_018.jpg GRAPHIC 288401
26 ex10-2_019.jpg GRAPHIC 339040
27 ex10-2_020.jpg GRAPHIC 269428
28 ex10-2_021.jpg GRAPHIC 192609
29 ex10-2_022.jpg GRAPHIC 50593
30 ex10-2_023.jpg GRAPHIC 404174
31 ex10-3_001.jpg GRAPHIC 376568
32 ex10-3_002.jpg GRAPHIC 394097
33 ex10-3_003.jpg GRAPHIC 465949
34 ex10-3_004.jpg GRAPHIC 319223
35 ex10-3_005.jpg GRAPHIC 554514
36 ex10-3_006.jpg GRAPHIC 527152
37 ex10-3_007.jpg GRAPHIC 531101
38 ex10-3_008.jpg GRAPHIC 539765
39 ex10-3_009.jpg GRAPHIC 553173
40 ex10-3_010.jpg GRAPHIC 461406
41 ex10-3_011.jpg GRAPHIC 510010
42 ex10-3_012.jpg GRAPHIC 470285
43 ex10-3_013.jpg GRAPHIC 505449
44 ex10-3_014.jpg GRAPHIC 467289
45 ex10-3_015.jpg GRAPHIC 456519
46 ex10-3_016.jpg GRAPHIC 486688
47 ex10-3_017.jpg GRAPHIC 433474
48 ex10-3_018.jpg GRAPHIC 572188
49 ex10-3_019.jpg GRAPHIC 472946
50 ex10-3_020.jpg GRAPHIC 405317
51 ex10-3_021.jpg GRAPHIC 95994
52 ex10-3_022.jpg GRAPHIC 99694
53 ex10-3_023.jpg GRAPHIC 424718
54 ex10-3_024.jpg GRAPHIC 506620
55 ex10-3_025.jpg GRAPHIC 454627
56 ex10-3_026.jpg GRAPHIC 416195
57 ex10-3_027.jpg GRAPHIC 415354
58 ex10-3_028.jpg GRAPHIC 368633
59 ex10-3_029.jpg GRAPHIC 438419
60 ex10-3_030.jpg GRAPHIC 391489
61 ex10-3_031.jpg GRAPHIC 99272
  Complete submission text file 0001493152-22-022928.txt   34970279

Data Files

Seq Description Document Type Size
62 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eltp-20220630.xsd EX-101.SCH 47931
63 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eltp-20220630_cal.xml EX-101.CAL 65933
64 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eltp-20220630_def.xml EX-101.DEF 164476
65 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eltp-20220630_lab.xml EX-101.LAB 377405
66 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eltp-20220630_pre.xml EX-101.PRE 295672
133 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1210296
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 221166292
SIC: 2834 Pharmaceutical Preparations